ORGO
NASDAQStockOrganogenesis Holdings Inc.
$2.63-0.03 (-0.94%)
52-Week Range
$2.65
$6.54
Key Stats
Market Cap
337.7M
P/E Ratio
23.86
Dividend Yield
—
Beta
1.39
Volume
349.2K
Avg Volume
882.3K
Performance
1M
-29.14%
3M
-45.13%
6M
-46.57%
YTD
-42.83%
1Y
-47.11%
3Y
+22.69%
5Y
-84.59%
Price Chart
ETF Exposure
ORGO is held by 63 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
PreviousPage 2 of 2
About ORGO ETF Exposure
Organogenesis Holdings Inc. (ORGO) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 337.7M, ORGO is a widely held institutional stock. The stock currently trades at $2.63. Investors can gain exposure to ORGO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ORGO, sorted by portfolio weight.